Education
About Us
Working with TipRanks
Follow Us
Meituan (HK:3690)
:3690
3690 Analyst Ratings
Moderate Buy
10 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
3690 Stock 12 Month Forecast
Average Price Target
HK$163.98
▲(24.42%Upside)
| Highest Price TargetHK$204.03 | Average Price TargetHK$163.98 | Lowest Price TargetHK$115.02 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
HK$162
Buy
22.91%
Upside
Reiterated
06/13/25
Meituan Dianping's overall stock score reflects its strong financial performance and strategic positioning. The company has demonstrated significant growth and operational efficiency, although competition and market challenges pose risks. Technical analysis and valuation present a moderate outlook, while positive earnings call insights support a favorable long-term view.
Macquarie
HK$115
Hold
-12.75%
Downside
Reiterated
06/24/25
Bernstein
HK$190→HK$150
Hold
13.81%
Upside
Downgraded
06/17/25
Nomura
HK$200→HK$176
Buy
33.54%
Upside
Reiterated
05/29/25
DBS
HK$206→HK$171
Buy
29.74%
Upside
Reiterated
05/27/25
Benchmark Co.
HK$210→HK$165
Buy
25.19%
Upside
Reiterated
05/27/25
CMB International Securities
HK$200.2→HK$181.6
Buy
37.78%
Upside
Reiterated
05/27/25
We remain positive on Meituan’s competitive edge in the FD industry, and believe industry competition should return to rationality in due course, but there will be a lack of visibility in the short term. We lower our 2025-2027E revenue/adj. NP forecasts by 1-2%/11-21% to account for the additional investment in the FD business, and incremental investment to support overseas expansion of the FD business. Our DCF-based TP was cut by 9% to HK$181.6 (previous: HK$200.20), translating into 25x 2025E adjusted PE. Maintain BUY. Proactively respond to competition and target to maintain market share. CLC segment rev/OP was 2%/10% better than consensus, thanks to better-than-expected UE expansion of FD aided by optimization in user subsidy.
Barclays
HK$117.75
Sell
-10.66%
Downside
Reiterated
05/27/25
CLSA
HK$195→HK$185
Buy
40.36%
Upside
Reiterated
05/27/25
CGS-CIMB
HK$166
Buy
25.95%
Upside
Reiterated
05/27/25
Citi
HK$217→HK$204
Buy
54.78%
Upside
Reiterated
05/27/25
J.P. Morgan
HK$165→HK$160
Buy
21.40%
Upside
Reiterated
05/26/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
HK$162
Buy
22.91%
Upside
Reiterated
06/13/25
Meituan Dianping's overall stock score reflects its strong financial performance and strategic positioning. The company has demonstrated significant growth and operational efficiency, although competition and market challenges pose risks. Technical analysis and valuation present a moderate outlook, while positive earnings call insights support a favorable long-term view.
Macquarie
HK$115
Hold
-12.75%
Downside
Reiterated
06/24/25
Bernstein
HK$190→HK$150
Hold
13.81%
Upside
Downgraded
06/17/25
Nomura
HK$200→HK$176
Buy
33.54%
Upside
Reiterated
05/29/25
DBS
HK$206→HK$171
Buy
29.74%
Upside
Reiterated
05/27/25
Benchmark Co.
HK$210→HK$165
Buy
25.19%
Upside
Reiterated
05/27/25
CMB International Securities
HK$200.2→HK$181.6
Buy
37.78%
Upside
Reiterated
05/27/25
We remain positive on Meituan’s competitive edge in the FD industry, and believe industry competition should return to rationality in due course, but there will be a lack of visibility in the short term. We lower our 2025-2027E revenue/adj. NP forecasts by 1-2%/11-21% to account for the additional investment in the FD business, and incremental investment to support overseas expansion of the FD business. Our DCF-based TP was cut by 9% to HK$181.6 (previous: HK$200.20), translating into 25x 2025E adjusted PE. Maintain BUY. Proactively respond to competition and target to maintain market share. CLC segment rev/OP was 2%/10% better than consensus, thanks to better-than-expected UE expansion of FD aided by optimization in user subsidy.
Barclays
HK$117.75
Sell
-10.66%
Downside
Reiterated
05/27/25
CLSA
HK$195→HK$185
Buy
40.36%
Upside
Reiterated
05/27/25
CGS-CIMB
HK$166
Buy
25.95%
Upside
Reiterated
05/27/25
Citi
HK$217→HK$204
Buy
54.78%
Upside
Reiterated
05/27/25
J.P. Morgan
HK$165→HK$160
Buy
21.40%
Upside
Reiterated
05/26/25
Best Analysts Covering Meituan
1 Month
xxx
Success Rate
9/14 ratings generated profit
Average Return
-2.22%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.29% of your transactions generating a profit, with an average return of -2.22% per trade.
3 Months
xxx
Success Rate
4/8 ratings generated profit
Average Return
+1.91%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.91% per trade.
1 Year
Success Rate
10/14 ratings generated profit
Average Return
-0.51%
reiterated a sell rating last month
Copying Jiong Shao's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of -0.51% per trade.
2 Years
xxx
Success Rate
4/6 ratings generated profit
Average Return
+12.92%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +12.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
3690 Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
10
16
15
25
14
Buy
0
0
0
0
0
Hold
0
0
0
1
4
Sell
1
1
1
2
1
Strong Sell
0
0
0
0
0
total
11
17
16
28
19
Each month's total comprises the sum of three months' worth of ratings.
3690 Financial Forecast
3690 Stock Forecast FAQ
What is HK:3690’s average 12-month price target, according to analysts?
Based on analyst ratings, Meituan’s 12-month average price target is 163.98.
What is HK:3690’s upside potential, based on the analysts’ average price target?
Meituan has 24.42% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Meituan a Buy, Sell or Hold?
Meituan has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 3 hold ratings and 1 sell ratings.
What is Meituan’s share price target?
The average share price target for Meituan is 163.98. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$204.03 ,and the lowest forecast is HK$115.02. The average share price target represents 24.42% Increase from the current price of HK$131.8.
The highest analyst share price target is HK$204.03 ,and the lowest forecast is HK$115.02. The average share price target represents 24.42% Increase from the current price of HK$131.8.
What do analysts say about Meituan?
Meituan’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Meituan?
To buy shares of HK:3690, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.